FitLife Brands: Roth Capital raises price target to $25 from $20.

FitLife Brands: Roth Capital raises price target to $25 from $20.

Roth Capital Partners has updated its price target for FitLife Brands (NASDAQ: FTLF) to $25, up from the previous $20. The move comes following the company's Q2 2025 earnings report and the acquisition of Irwin Naturals, which closed after the end of the quarter.

According to Roth Capital analyst S. Mcgowan, the updated price target reflects the analyst's expectations for the company's earnings per share (EPS) for the quarter. Mcgowan expects FitLife Brands to earn $0.18 per share for Q2 2025, up from the previous consensus estimate of $0.18 per share [1].

The company reported a 5% year-over-year decline in revenue to $16.1 million for Q2 2025, with online sales accounting for $10.4 million or 65% of total revenue. Gross profit fell by 9%, and gross margin decreased to 42.8%. Net income was $1.7 million, down from $2.6 million in the prior year, primarily due to elevated M&A expenses related to the acquisition of Irwin Naturals [2].

The acquisition of Irwin Naturals, a nutritional supplement brand, is expected to generate significant synergies for FitLife Brands. The company expects the combined FitLife and Irwin businesses to generate in excess of $120 million of revenue and adjusted EBITDA of between $20 million to $25 million for the first full year of operations [2].

Roth Capital Partners' updated price target reflects the analyst's optimism about the company's ability to integrate Irwin Naturals and achieve revenue synergies. However, the analyst also noted that the company faces challenges in the MRC segment and Dr. Tobias brand, which may impact organic revenue growth in 2025 [2].

References:

[1] https://www.marketbeat.com/instant-alerts/roth-capital-estimates-fitlife-brands-q2-earnings-2025-08-08/
[2] https://seekingalpha.com/news/4485849-fitlife-brands-outlines-120m-combined-revenue-target-following-irwin-naturals-acquisition